ACE2 and inflammation: Higher circulating levels of troponin in patients with and without ASCVD might be a consequence of direct SARS-CoV-2 effects on cardiomyocytes [39] or through up-regulation of ACE2 in the heart and coronary vessels, hypoxia and immune mechanisms of myocardial inflammation [6,40].